Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms [124I]meta-Iodobenzylguanidine |
Target- |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atrial Fibrillation | Phase 3 | CA | 31 Mar 2015 | |
Carcinoid Tumor | Phase 3 | CA | 15 Jun 2011 | |
Neuroblastoma | Phase 3 | CA | 15 Jun 2011 | |
Pheochromocytoma | Phase 3 | CA | 15 Jun 2011 | |
Thyroid Cancer, Medullary | Phase 3 | CA | 15 Jun 2011 | |
Brain Cancer | Phase 2 | GB | 28 Feb 2014 | |
Neuroendocrine Tumors | Phase 1 | US | Jubilant Draximage, Inc.Startup | 09 Apr 2013 |
Neuroendocrine Tumors | Phase 1 | US | 09 Apr 2013 | |
Thyroid Cancer | Phase 1 | US | 09 Apr 2013 | |
Thyroid Cancer | Phase 1 | US | Jubilant Draximage, Inc.Startup | 09 Apr 2013 |
Phase 1/2 | 36 | arnylxyenv(wpntuyaenq) = olmbpkkaje cduvrcprrj (fosozzxdhv, wdiwmvrovg - umtgfvfozs) View more | - | 21 Jun 2021 |